swertisin has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, G; Gupta, S; Murumkar, P; Pappachan, A; Patel, D; Shah, H; Shah, R; Srivastava, A; Vakani, M | 1 |
| Bhatt, LK; Khanna, A; Mokashi, P; Pandita, N | 1 |
2 other study(ies) available for swertisin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Swertisin, a novel SGLT2 inhibitor, with improved glucose homeostasis for effective diabetes therapy.
Topics: Animals; Apigenin; Caco-2 Cells; Computer Simulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; HEK293 Cells; Homeostasis; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Kidney; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Phytotherapy; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Topics: Animals; Antioxidants; Apigenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavonoids; Gentianaceae; Glucose; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Plant Extracts; Rats; Streptozocin | 2017 |